Literature DB >> 1933834

Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells.

J K Tillotson1, D P Rose.   

Abstract

The growth rate of DU145 prostate cancer cells in vitro is slowed considerably by changing the growth medium every 24 h, suggesting dependence upon endogenously-secreted growth factors. Because previous studies have identified epidermal growth factor (EGF) in the conditioned medium from DU145 cells, [35S]labeled EGF was selectively immunoprecipitated from the culture medium at 24-h intervals for quantitation. Under the culture conditions used, there was an initial phase of slow growth, the EGF level secreted per cell was highest on day 3 after plating, and an increase in cell number was most evident between days 3 and 4. Finally, growth was assayed under culture conditions where the medium was replaced every 24 h with fresh medium in the absence or presence of 10 ng/ml added EGF. The EGF was able to increase the cell growth up to the levels seen in cultures where the medium was unchanged during the entire period. We interpret these results as evidence that endogenously secreted EGF-like growth factors participate in an autocrine growth stimulation of DU145 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933834     DOI: 10.1016/0304-3835(91)90216-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

3.  Activating stress-activated protein kinase-mediated cell death and inhibiting epidermal growth factor receptor signaling: a promising therapeutic strategy for prostate cancer.

Authors:  Raj Kumar; Sowmyalakshmi Srinivasan; Pallab Pahari; Jürgen Rohr; Chendil Damodaran
Journal:  Mol Cancer Ther       Date:  2010-08-24       Impact factor: 6.261

4.  Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway.

Authors:  Bo Peng; Janice Ortega; Liya Gu; Zhijie Chang; Guo-Min Li
Journal:  J Biol Chem       Date:  2019-03-11       Impact factor: 5.157

5.  Tumor spheroid invasion in epidermal growth factor gradients revealed by a 3D microfluidic device.

Authors:  Young Joon Suh; Mrinal Pandey; Jeffrey E Segall; Mingming Wu
Journal:  Phys Biol       Date:  2022-03-10       Impact factor: 2.583

6.  Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.

Authors:  Ludmila Sviridonov; Masha Dobkin-Bekman; Boris Shterntal; Fiorenza Przedecki; Linor Formishell; Shani Kravchook; Liat Rahamim-Ben Navi; Tali Hana Bar-Lev; Marcelo G Kazanietz; Zhong Yao; Rony Seger; Zvi Naor
Journal:  Mol Cell Endocrinol       Date:  2013-02-01       Impact factor: 4.102

Review 7.  Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.

Authors:  E R Sherwood; C Lee
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.

Authors:  H Xie; T Turner; M H Wang; R K Singh; G P Siegal; A Wells
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

9.  Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.

Authors:  J E Damber; A Bergh; B Assarsson; M Gåfvels
Journal:  Urol Res       Date:  1995

10.  Epidermal growth factor receptor structural alterations in gastric cancer.

Authors:  Cátia Moutinho; Ana R Mateus; Fernanda Milanezi; Fátima Carneiro; Raquel Seruca; Gianpaolo Suriano
Journal:  BMC Cancer       Date:  2008-01-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.